NO983849L - Peptidderivater - Google Patents

Peptidderivater

Info

Publication number
NO983849L
NO983849L NO983849A NO983849A NO983849L NO 983849 L NO983849 L NO 983849L NO 983849 A NO983849 A NO 983849A NO 983849 A NO983849 A NO 983849A NO 983849 L NO983849 L NO 983849L
Authority
NO
Norway
Prior art keywords
peptide
Prior art date
Application number
NO983849A
Other languages
English (en)
Other versions
NO983849D0 (no
Inventor
Ronald Cotton
Philip Neil Edwards
Richard William Arthur Luke
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603855.9A external-priority patent/GB9603855D0/en
Priority claimed from GBGB9620819.4A external-priority patent/GB9620819D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO983849D0 publication Critical patent/NO983849D0/no
Publication of NO983849L publication Critical patent/NO983849L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
NO983849A 1996-02-23 1998-08-21 Peptidderivater NO983849L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9603855.9A GB9603855D0 (en) 1996-02-23 1996-02-23 Peptide derivatives
GBGB9620819.4A GB9620819D0 (en) 1996-10-05 1996-10-05 Chemical compounds
PCT/GB1997/000438 WO1997031023A1 (en) 1996-02-23 1997-02-18 Peptide derivatives

Publications (2)

Publication Number Publication Date
NO983849D0 NO983849D0 (no) 1998-08-21
NO983849L true NO983849L (no) 1998-10-21

Family

ID=26308795

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983849A NO983849L (no) 1996-02-23 1998-08-21 Peptidderivater

Country Status (29)

Country Link
US (1) US6087336A (no)
EP (1) EP0882066B1 (no)
JP (1) JP3468528B2 (no)
KR (1) KR19990087123A (no)
CN (1) CN1116305C (no)
AR (1) AR005974A1 (no)
AT (1) ATE196152T1 (no)
AU (1) AU722877C (no)
BR (1) BR9707720A (no)
CA (1) CA2242809A1 (no)
CZ (1) CZ266398A3 (no)
DE (1) DE69703032T2 (no)
DK (1) DK0882066T3 (no)
ES (1) ES2151716T3 (no)
GB (1) GB9702377D0 (no)
GR (1) GR3034361T3 (no)
HK (1) HK1015383A1 (no)
HR (1) HRP970099B1 (no)
HU (1) HU222198B1 (no)
ID (1) ID16037A (no)
IL (1) IL125804A0 (no)
NO (1) NO983849L (no)
NZ (1) NZ330944A (no)
PL (1) PL328486A1 (no)
PT (1) PT882066E (no)
SK (1) SK114998A3 (no)
TR (1) TR199801614T2 (no)
TW (1) TW492978B (no)
WO (1) WO1997031023A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives
WO1997046578A1 (en) 1996-06-07 1997-12-11 Zeneca Limited Peptide derivatives
GB9621836D0 (en) * 1996-10-19 1996-12-11 Zeneca Ltd Peptide compounds
GB9624562D0 (en) * 1996-11-27 1997-01-15 Zeneca Ltd Peptide derivatives
GB9625865D0 (en) * 1996-12-12 1997-01-29 Zeneca Ltd Peptides
GB9809021D0 (en) 1998-04-29 1998-06-24 Zeneca Ltd Chemical process
US6262080B1 (en) 1998-12-31 2001-07-17 Avantis Pharmaceuticals Inc. 3-(thio-substitutedamido)-lactams useful as inhibitors of matrix metalloproteinase
AU1926700A (en) * 1998-12-31 2000-07-24 Aventis Pharmaceuticals Inc. 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase
GB9912911D0 (en) * 1999-06-04 1999-08-04 Zeneca Ltd Chemical process
US6485740B1 (en) * 2000-03-14 2002-11-26 Yutoku Pharmaceutical Ind., Co., Ltd. Transdermal methotrexate preparations
GB0017979D0 (en) * 2000-07-22 2000-09-13 Astrazeneca Ab Chemical process
GB0130285D0 (en) 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process
GB0130286D0 (en) * 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process
GB0317733D0 (en) 2003-07-29 2003-09-03 Novartis Ag Organic compounds
EP2366448B1 (en) * 2010-03-16 2016-07-27 Amminex Emissions Technology A/S Method and device for controlled dosing of a gas with fluctuating supply pressure

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474778A (en) * 1983-11-09 1984-10-02 E. R. Squibb & Sons, Inc. Lactam containing compounds, their pharmaceutical compositions and method of use
US4680283A (en) * 1984-09-26 1987-07-14 Merck & Co., Inc. Analogs of substance P and eledoisin
DE3711335A1 (de) * 1987-04-03 1988-10-20 Merck Patent Gmbh Aminosaeurederivate
US5331089A (en) * 1988-03-25 1994-07-19 Merck Sharpe & Dohme, Ltd. Peptides useful as tachykinin agonists
EP0360390A1 (en) * 1988-07-25 1990-03-28 Glaxo Group Limited Spirolactam derivatives
US5223485A (en) * 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
WO1992002543A1 (en) * 1990-08-01 1992-02-20 Cytel Corporation Novel immunosuppressant peptides
DE4034829A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh Cyclopeptide
AU2468392A (en) * 1991-08-29 1993-04-05 Cytel Corporation Novel immunosuppressants
DK0644197T3 (da) * 1993-06-04 1999-06-07 Vertex Pharma Peptidphosphinyloxymethylketoner som inhibitorer af interleukin-1beta-konverterende enzymer
AU698962B2 (en) * 1993-09-14 1998-11-12 Epimmune, Inc. Alteration of immune response using pan DR-binding peptides
AU2238395A (en) * 1994-04-01 1995-10-23 Immulogic Pharmaceutical Corporation Haptenated peptides and uses thereof
JPH10508035A (ja) * 1995-03-24 1998-08-04 モレキュメティックス リミテッド βシート模倣物およびプロテアーゼインヒビターとしてのその使用
US5719296A (en) * 1995-10-30 1998-02-17 Merck & Co., Inc. Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins
WO1997016425A1 (en) * 1995-10-30 1997-05-09 Merck & Co., Inc. Novel inhibitors of peptide binding to mhc class ii proteins
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives

Also Published As

Publication number Publication date
TR199801614T2 (xx) 1998-11-23
JP2000508623A (ja) 2000-07-11
JP3468528B2 (ja) 2003-11-17
HU222198B1 (hu) 2003-05-28
NO983849D0 (no) 1998-08-21
EP0882066A1 (en) 1998-12-09
CN1116305C (zh) 2003-07-30
KR19990087123A (ko) 1999-12-15
PL328486A1 (en) 1999-02-01
DK0882066T3 (da) 2000-12-18
DE69703032D1 (de) 2000-10-12
PT882066E (pt) 2000-12-29
CA2242809A1 (en) 1997-08-28
AR005974A1 (es) 1999-07-21
ES2151716T3 (es) 2001-01-01
HUP9901189A2 (hu) 1999-08-30
AU722877C (en) 2002-12-05
NZ330944A (en) 2000-04-28
ATE196152T1 (de) 2000-09-15
AU722877B2 (en) 2000-08-10
HRP970099A2 (en) 1998-04-30
US6087336A (en) 2000-07-11
GB9702377D0 (en) 1997-03-26
HRP970099B1 (en) 2001-10-31
HUP9901189A3 (en) 2000-07-28
SK114998A3 (en) 1999-02-11
IL125804A0 (en) 1999-04-11
EP0882066B1 (en) 2000-09-06
ID16037A (id) 1997-08-28
GR3034361T3 (en) 2000-12-29
AU1803597A (en) 1997-09-10
DE69703032T2 (de) 2001-04-12
CZ266398A3 (cs) 1998-11-11
HK1015383A1 (en) 1999-10-15
TW492978B (en) 2002-07-01
BR9707720A (pt) 1999-04-06
CN1213379A (zh) 1999-04-07
WO1997031023A1 (en) 1997-08-28

Similar Documents

Publication Publication Date Title
ATE208395T1 (de) Thiophenopyrimidine
ATE262512T1 (de) Arylalkanoylpyridazine
DE69737314D1 (de) Netzeinschaltvorrichtung
NO985680D0 (no) Peptidderivater
ATE208773T1 (de) Chinoxalindione
NO983849D0 (no) Peptidderivater
BR9508433A (pt) Peptídeos
DK0832553T3 (da) Mejetærsker
TR199701666A3 (tr) Sismanliga karsi proteinler
BR9606756A (pt) Peptídeo
NO981052D0 (no) Peptidderivater
ATE235511T1 (de) Vielfältig verzweigte peptidkonstruktionen
NO981051D0 (no) Peptidderivater
DE69706982T2 (de) Wärmeisolationspaneel
DK1017798T3 (da) Lunasinpeptider
NO20000976D0 (no) Peptider
SE9504467D0 (sv) Peptide
BR1100812A (pt) Peptìdeo
DE29607102U1 (de) PortionsetagEre
ID17224A (id) Sediaan
BR7600030U (pt) Cinturita
FI964540A0 (fi) Backaokningsanordning
FIU960211U0 (fi) Turvasarana
BR9603463A (pt) Hidro-coleta
BR9602174A (pt) Lecton massoterapeutico

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application